✦ LIBER ✦

Effective chemotherapy for advanced carcinoma of the cervix with bleomycin, cisplatin, vincristine, and methotrexate

✍ Scribed by C. Julian Rosenthal; Neekianud Khulpateea; John Boyce; Sushil Mehrotra; Steven Tamarin

Publisher: John Wiley and Sons
Year: 1983
Tongue: English
Weight: 819 KB
Volume: 52
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19831201)52:11<2025::aid-cncr2820521109>3.0.co;2-o

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination chemotherapy with cisplatin,

Combination chemotherapy with cisplatin, methotrexate, bleomycin, and vincristine (CABO) in advanced squamous cell carcinoma of the head and neck

✍ Marcel Rozencweig; Pierre Dodion; Uta Bruntsch; Walter Gallmeier; Michel Clavel; 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 547 KB

A combination of cisplatin, methotrexate, bleomycin, and vincristine (CABO) was assessed in advanced epidermoid head and neck cancer. Among 72 patients with recurrent or metastatic disease and measurable lesions, there were 9 complete and 27 partial responses for an overall response rate of 50%. The

Combination chemotherapy with methotrexa

Combination chemotherapy with methotrexate, bleomycin, and vincristine with or without cisplatin in advanced squamous cell carcinoma of the head and neck

✍ M. Clavel; F. Cognetti; P. Dodion; J. Wildiers; R. Rosso; A. Rossi; B. Gignoux; 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 449 KB 👁 2 views

## For the EORTC Head and Neck Cooperative Group A total of 185 eligible patients with advanced inoperable squamous cell carcinoma of the head and neck were randomized into two groups; the cisplatin, methotrexate, bleomycin, and vincristine (CABO) group received cisplatin (50 mg/m2; day 4), methot

Weekly chemotherapy with cisplatin, vinc

Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide is an effective treatment for advanced thymic carcinoma

✍ Kiyotaka Yoh; Koichi Goto; Gen-ichiro Ishii; Seiji Niho; Hironobu Ohmatsu; Kaoru 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 1 views

## Abstract ## BACKGROUND Thymic carcinoma is a rare neoplasm that often disseminates or metastasizes. The role of chemotherapy in treating this malignancy is unclear. The purpose of the current study was to determine the efficacy and tolerability of a weekly chemotherapy regimen consisting of cis

Sequential methotrexate and 5-fluorourac

Sequential methotrexate and 5-fluorouracil with bleomycin and cisplatin in the chemotherapy of advanced squamous cancer of the head and neck

✍ Steven E. Vogl; Arnold Komisar; Barry H. Kaplan; Paul F. Engstrom; Omar H. Kasul 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 520 KB

Vincristine, cisplatin, and bleomycin wi

Vincristine, cisplatin, and bleomycin with surgery in the management of advanced metastatic nonseminomatous testis tumors

✍ John N. Wettlaufer; Alan S. Feiner; William A. Robinson 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 629 KB

Most effective treatment regimens for advanced nonseminomatous testis tumors (NSIT) employ vinblastine (V), cisplatin (CDDP), and bleomycin (B) and adjunctive surgery. The toxicity of many of these multidrug programs, primarily from vinblastine-induced myelosuppression has resulted in significant pa

Phase II study of mitomycin-C, vincristi

Phase II study of mitomycin-C, vincristine, and bleomycin in advanced squamous cell carcinoma of the uterine cervix

✍ Laurence H. Baker; Michael I. Opipari; Ronald M. Izbicki 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 250 KB 👁 2 views